Tuesday January 12, 5:00 pm Eastern Time UroMed CFO resigns
NORWOOD, Mass., Jan 12 (Reuters) - UroMed Corp., maker of medical products for urinary problems, said Tuesday Paul Murphy, chief financial officer, has resigned to pursue business interests outside the medical industry.
Domenic Micale, who has been with UroMed since 1996, has been promoted to director of finance. Micale and John Simon, UroMed's president and CEO since its 1990 inception, together will be assuming all of Murphy's former responsibilities, the company said.
UroMed is engaged in developing urological products, with primary emphasis on the treatment of prostate cancer. |
